Breaking AI & Tech News Analyzed

For the first time, scientists have observed a 'civil war' in wild chimpanzees, where a once unified group turned on itself, leading to a years-long conflict. In a study published in the journal Science, researchers detail the dramatic shift in behavior among the Ngogo chimpanzee group in Uganda's Kibale national park.Primatologist Aaron Sandel, who led the research, noted that the conflict began in 2015 when the group's dynamics started to change. A change in social hierarchies, the death of key older individuals, and a disease outbreak in 2017 contributed to the group's fracture. By 2018, two distinct groups had emerged: the western chimps and the central chimps.The conflict escalated into 24 sustained and coordinated attacks by the western group on the central group over seven years, resulting in the deaths of at least seven adult males and 17 infants. This level of in-group violence is rare in the animal kingdom and has significant implications for understanding human conflict.Sandel suggests that human activities disrupting social cohesion, such as deforestation, climate change, or disease outbreaks, could make such inter-group conflicts more common among chimpanzees, who are already threatened with extinction. The study highlights the fragility of social ties and the potential for group cohesion to be disrupted under specific circumstances.Brian Wood, an evolutionary anthropologist, noted that the western chimps increased their Darwinian fitness by decreasing the survival and reproduction of their former community members. This conflict has resulted in the lowest survivorship ever documented in a wild chimpanzee community.

The two‑child benefit cap, introduced in 2015 by Chancellor George Osborne as a fairness measure, has been widely criticised for penalising families rather than influencing birth rates. Eleven years on, evidence shows the policy did not reduce family size but instead increased hardship for the poorest households.Research estimates that the cap pushed 350,000 children into poverty and drove another 700,000 deeper into deprivation. The impact fell disproportionately on the most vulnerable universal‑credit claimants, with a notable over‑representation of Muslim and Jewish families. Affected children missed out on school uniforms, extracurricular activities, and even regular meals.On Monday, the government announced the cap’s removal – a move that analysts say could deliver the most significant reduction in child poverty seen in a single parliamentary term. Modelling suggests that by 2030 450,000 children could be lifted out of poverty, while roughly 480,000 families may see an annual boost of £4,100. Parents anticipate being able to avoid food banks, afford hot school meals, and prevent bullying linked to clothing.The reversal was not inevitable. Persistent campaigning by think‑tanks, charities, and a handful of rebellious Labour MPs – some of whom faced suspension for defying party whips – forced the issue onto the political agenda. Nevertheless, the editorial notes that an estimated four million children will remain in poverty without further systemic reforms, such as raising Universal Credit rates and increasing local housing allowances.Public opinion remains divided: a recent YouGov poll found that six in ten Britons previously supported keeping the cap, though support for removal rose when the policy was framed as giving every child a good start. The editorial warns that other parties, including Reform UK, have pledged to reinstate the limit, underscoring the need for Labour to consolidate this victory and push for broader anti‑poverty measures.

Matthew Macfadyen headlines the new Sky Atlantic series ‘The Miniature Wife’, playing scientist Les Littlejohn, a brilliant but ethically dubious researcher who accidentally shrinks his wife Lindy (Elizabeth Banks) to six inches tall. The premise promises a darkly comic exploration of marital power dynamics and modern misogyny. However, the show quickly abandons this fertile ground. Showrunners Jennifer Ames and Steve Turner opt for a frenetic, screwball tone that feels forced, leaving the underlying commentary underdeveloped. The central conceit – a miniature wife trapped in a dollhouse – is treated more as a visual gag than a vehicle for satire. The series is littered with side plots that never coalesce. A subplot about a misattributed short story attempts to touch on authorship and truth in the digital age, yet it remains a superficial gesture. Likewise, the ensemble cast—including Zoe Lister‑Jones as a lab overseer, O‑T Fagbenle as a lovelorn colleague, and Sian Clifford as Lindy’s agent—offers colorful moments but fails to achieve narrative momentum. Visually, the production delivers inventive set pieces: Lindy’s daring escapes from towering household objects and explosive laboratory experiments provide occasional laughs. Nevertheless, the novelty wears thin before the series’ nearly ten‑hour runtime concludes. The original short story by Manuel Gonzales required far more expansion than the show supplies, resulting in a stretched‑out narrative that would have benefited from a tighter format. In short, while Macfadyen’s performance is competent, it is largely wasted in a series that promises depth but delivers only scattered comedy. ‘The Miniature Wife’ may satisfy viewers seeking light‑hearted antics, but it falls short of the incisive satire its premise suggests. The series is available on Sky Atlantic, streaming on Now in the UK and on Stan in Australia.

A British warship together with a Royal Air Force P‑8 maritime patrol aircraft monitored three Russian submarines that were trying to survey key undersea infrastructure in the North Atlantic, the defence secretary John Healey said at a Downing Street briefing.Healey explained that the operation, which lasted **over a month**, took place not within UK territorial waters but in the country's exclusive economic zone – the area extending up to 200 nautical miles from the coastline and bordering neighbouring zones.The Russian vessels comprised an Akula‑class nuclear‑powered submarine and two deep‑sea research submarines from the GUGI directorate, a unit that normally conducts peacetime surveys of underwater infrastructure but possesses the capability to damage it in conflict.According to the minister, the British forces tracked and deterred any malign activity around the submarines 24/7, deploying regular sonar buoys to demonstrate continuous monitoring. The presence of the Royal Navy ship and the P‑8 aircraft, supported by NATO allies, left the Russian crews with “no doubt that they were being watched”.As a result, the Akula submarine “retreated home” and the two GUGI subs subsequently exited the UK’s maritime zone, heading northward. The operation involved **about 500 UK personnel**.Healey stressed that there was **no evidence of damage** to any pipelines or cables, but that UK forces and allies would verify the integrity of the infrastructure. He warned President Putin that any attempt to sabotage the network would “not be tolerated and will have serious consequences”.The defence secretary framed the incident as proof that Moscow is “the primary threat to the UK and to NATO”, underscoring the need for heightened vigilance over undersea assets amid the broader security fallout from the Ukraine war and recent tensions in the Middle East.He also linked the episode to broader defence policy, stating that the successful deterrence demonstrates the UK’s ability to detect, deter and, if necessary, respond to threats against its critical maritime infrastructure, while calling for continued investment in defence capabilities.

The ceasefire deal between Iran and the US has been hailed as a significant achievement for China, which has been actively working to promote de-escalation and an end to hostilities in the region. Beijing's powerbrokers are being credited with pushing Iran towards agreeing to the ceasefire, bolstering its status as a regional mediator.In China's tightly censored domestic media, articles basking in the glory of China being the grown-up in the room at a time of international crisis were allowed to circulate. China's role in the negotiations was confirmed by US President Donald Trump, who told the Agence France-Presse news agency that he believed China had got Iran to agree to a ceasefire.However, some analysts are sceptical about how influential China could actually have been in the late-night discussions. The deal is advantageous to Iran, and encouraging the regime to agree to it would have been like 'pushing an open door', according to one analyst. Nicholas Lyall, a senior researcher at Trends, a research and advisory firm in Abu Dhabi, said: 'In terms of whether China had to do much pushing of Iran for it to agree to the temporary ceasefire, and whether Iran was swayed by this reported Chinese effort, it's essential to clarify what Iran has actually agreed to.'Officially, China has not confirmed or denied reports that it played an active role in the Islamabad negotiations. At a press conference on Wednesday, the foreign ministry spokesperson Mao Ning said only that China 'had been actively working to promote de-escalation and an end to all hostilities'. China's economic interests are also at stake, as the risk of a global recession and soaring fossil fuel prices poses a threat to the Chinese economy, which is heavily dependent on exports.Analysts are even more sceptical of the idea that China might act as the guarantor of any ceasefire agreement in the Middle East. Song Bo, a fellow at the Center for International Security and Strategy at Tsinghua University, said: 'China doesn't have a direct stake with any of the parties in the Middle East. Acting as a guarantor for a ceasefire would be an extremely high-cost diplomatic undertaking, and I don't think China would commit to that easily.'

A 47‑year‑old woman who had endured three life‑threatening autoimmune diseases for more than a decade is now living a near‑normal life after an experimental CAR‑T cell therapy reset her immune system at University Hospital Erlangen in Germany.Before the procedure she had exhausted nine different treatments with no lasting benefit, relying on daily blood transfusions and continuous anticoagulation to manage her illnesses.Within weeks of the infusion, doctors observed rapid improvement in all three conditions—a world‑first outcome. She has remained in treatment‑free remission for 14 months and has largely returned to everyday activities.Prof Fabian Müller, who led the team, called the speed and depth of the response “remarkable” and said the therapy “significantly improved her quality of life.” He emphasized that clinical trials are required to determine how durable the effect is and whether it can help other autoimmune patients.The patient suffered from three distinct disorders: autoimmune haemolytic anaemia (AIHA), where rogue immune cells destroy red blood cells; immune thrombocytopenia (ITP), which depletes platelets and raises bleeding risk; and antiphospholipid syndrome (APS), which promotes dangerous blood clots. All three stem from malfunctioning B‑cells.With no conventional options left, doctors turned to CAR‑T therapy, a technique that has revolutionised treatment for certain cancers. They harvested her white‑blood cells, isolated the T‑cells, engineered them to recognise the CD19 protein on B‑cells, and reinfused the modified cells.The engineered T‑cells swiftly eliminated the pathogenic B‑cells. She received her last blood transfusion a week after treatment and was able to perform routine tasks within two weeks. Follow‑up tests showed a reconstituted, healthy B‑cell population, suggesting an immune reset. The findings were published in the journal Med.She still exhibits a mildly low white‑cell count and slightly elevated liver enzymes, which researchers attribute to the cumulative impact of prior therapies rather than the CAR‑T product.Rheumatology expert Prof Ben Parker of Manchester University NHS Foundation Trust described the case as encouraging, noting that “the prolonged response off normal therapy suggests there has been an immune reset.” However, he warned that case reports alone cannot confirm efficacy and highlighted ongoing trials for lupus, myositis, multiple sclerosis, systemic sclerosis, vasculitis, and other autoimmune conditions.

The UK government has pledged £380 million to accelerate the build‑out of a new battery factory in Somerset that will supply Jaguar Land Rover (JLR) with cells for its forthcoming electric Range Rover and Jaguar models. The plant, operated by Tata’s battery subsidiary Agratas, was highlighted during a site visit by Business Secretary Peter Kyle, who emphasized the grant’s role in safeguarding jobs and driving economic growth. When fully operational, the gigafactory is projected to employ 4,200 workers and deliver up to 40 GWh of battery capacity annually—enough for hundreds of thousands of electric vehicles. It will become the UK’s second high‑volume battery facility after the Chinese‑owned AESC plant in Sunderland. Construction remains in its early stages, with only a steel frame erected so far. Although the original timetable targeted production start‑up in 2026, delays have pushed the expected commencement to the end of 2027. Agratas has reduced the footprint of the first building but claims the change reflects more efficient process design rather than a cut‑back in output. JLR, the nation’s largest automotive employer, had planned to launch its electric Range Rover in 2025, but the debut has slipped to 2026 and the vehicle is still not on sale. The postponement follows a broader trend of EV manufacturers worldwide scaling back or postponing battery projects after over‑optimistic forecasts of rapid consumer migration from petrol. Recent spikes in petrol prices—spurred by geopolitical tensions linked to Donald Trump’s war in Iran—could make electric cars more appealing, potentially justifying the sizeable capital commitments required for a transition to EV production. Until the Somerset facility becomes operational, JLR will continue to source batteries from AESC. That arrangement was confirmed last year by investment bank Société Générale, though references to JLR have since been removed from public statements. In addition to the battery grant, Tata previously secured a £500 million pledge to modernise its Welsh steelworks with electric arc furnaces, underscoring the government’s broader push for greener industrial capacity. Peter Kyle said the investment, alongside other automotive research initiatives announced on the same day, would “boost economic growth, secure jobs and put more money in people’s pockets.” He added that the UK’s “modern industrial strategy” provides the stability needed for long‑term planning. Earl Wiggins, Agratas’s vice‑president for UK manufacturing, welcomed the funding, noting it will enable the company to “deliver net‑zero goals and strengthen the UK’s position as a global leader in battery manufacturing.” He projected that over 2,200 staff would be on‑site within the next year, with further growth thereafter.

The UK's reliance on glyphosate, a widely used herbicide, has come under fire from campaigners who argue that its use has spiralled out of control. Glyphosate, known for its effectiveness in killing weeds, has been linked to various health risks, including cancer, and environmental damage.Originally pioneered by Scottish farmers in the 1980s to dry crops before harvest, the use of glyphosate has expanded globally. In the UK, over 2,200 tonnes of glyphosate were applied in 2024, with more than half used on wheat and other cereals. This represents a 10-fold increase in usage over the past three decades.Despite the World Health Organization classifying glyphosate as 'probably carcinogenic to humans' in 2015, its use has remained high. Bayer, the manufacturer, maintains that its herbicides do not cause cancer, but this stance is contested by many health and environmental organizations.Campaigners, including Nick Mole of Pesticide Action Network UK, are urging the government to phase out and ultimately ban glyphosate, citing its links to a range of cancers and other life-threatening diseases, as well as its impact on the environment. They argue that safer, more sustainable alternatives are available and should be adopted by farmers and local councils.However, some agricultural experts, like Helen Metcalfe of Rothamsted Research, suggest that glyphosate is used differently in the UK compared to the US, where genetically modified crops are involved. The shift towards 'regenerative' farming practices has contributed to the increased use of glyphosate, as it helps protect soil health and prevent erosion.The debate over glyphosate's safety and environmental impact continues, with the EU banning its use in pre-harvest desiccation in 2023 due to concerns about food accumulation. In the US, Bayer has offered $7.25bn to settle lawsuits alleging that Roundup, which contains glyphosate, can cause cancer. The UK government maintains that pesticide use is strictly regulated and only approved if it does not harm human or animal health or the environment.

The UK government announced legislation that will protect disabled claimants from an automatic reassessment of benefits when they begin paid employment or volunteering. The measure, dubbed the “right to try”, is slated to take effect at the end of April and aims to remove the fear of losing financial support that many say discourages job‑seeking. Minister for Social Security and Disability Sir Stephen Timms framed the policy as a reassurance for people “stranded in the benefits system”. He emphasized that the change also extends to volunteering, which he described as a vital stepping‑stone toward sustainable employment. The new rules will apply to recipients of Employment and Support Allowance (ESA), Personal Independence Payment (PIP) and the health element of Universal Credit. Under the current system, taking up work can trigger a reassessment that often leads to reduced or withdrawn support, a risk that has deterred many disabled individuals from seeking employment. Disability advocates welcomed the development but cautioned that it does not tackle the deeper obstacles faced by disabled job‑seekers. James Taylor, a director at the charity Scope, called the policy “a step in the right direction” but warned that “the odds are stacked against disabled people when it comes to finding suitable work”. He urged the government to fund personalised employment support and to halt further benefit cuts. Research from the flexible‑working nonprofit Timewise underscores the challenge: only 2.5% of long‑term sick or disabled individuals who are economically inactive manage to return to work each year, and more than half of those jobs last fewer than four months. Mikey Erhardt of Disability Rights UK highlighted that a secure “right to try” is essential to ensure that anyone who tries work can retain the same level of support if the venture fails. Critics also noted that the announcement coincides with a controversial reduction to the health element of Universal Credit, which will be halved for new claimants and frozen unless stricter eligibility criteria are met. Timms acknowledged the pressure this creates, saying the previous system forced people to prove they were “too unwell to work”. Campaigners fear the simultaneous cuts will exacerbate financial strain for disabled claimants already navigating an uncertain labour market. Erhardt warned that “hundreds of thousands of disabled people will experience yet another cut in living standards”, arguing that successive governments have treated social security more as a coercive tool than a safety net.